Immunic, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.0M | $139.1M | $86.9M |
| FY2022 | $14.1M | $127.8M | $106.7M |
| FY2023 | $25.4M | $54.3M | $46.7M |
| FY2024 | $22.4M | $40.9M | $35.7M |
| FY2025 | $30.7M | $24.1M | $15.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.0M | $139.1M | $86.9M |
| FY2022 | $14.1M | $127.8M | $106.7M |
| FY2023 | $25.4M | $54.3M | $46.7M |
| FY2024 | $22.4M | $40.9M | $35.7M |
| FY2025 | $30.7M | $24.1M | $15.5M |